Serum Institute of India Gets CDSCO Panel Nod for Phase III CT of Inactivated Salk Polio Vaccine Dr. Divya Colin16 July 2023 6:00 PM ISTNew Delhi: Based on the interim report of the Phase II clinical trial of the Inactivated Salk Polio Vaccine (Adsorbed) presented by vaccine maker...
WHO prequalifies SII Multivalent meningococcal meningitis vaccine Ruchika Sharma13 July 2023 2:10 PM ISTMenFive is approved by WHO for use in individuals 1 through 85 years of age and will initially be available for use in reactive vaccine campaigns for...
Lack of testing facilities: Centre waives testing requirement for SII Cy-Tb injection at Govt labs Ruchika Sharma19 Jun 2023 12:30 PM ISTNew Delhi: The Centre has waived the requirement for testing of Cy-Tb injection, meant for detection of latent tuberculosis and manufactured by the...
Delete defamatory content against Serum Institute of India: Bombay HC directs two individuals Ruchika Sharma6 Jun 2023 12:35 PM ISTThe suit said the defendants had also been posting incorrect information that implied the Covishield vaccine was the cause of deaths of multiple...
Serum Institute has produced five to six million Covovax doses: Adar Poonawalla Ruchika Sharma24 April 2023 1:30 PM ISTCovovax is the only COVID vaccine made in India which is approved in the US and Europe. Currently, the demand is very small, Poonawalla said.
SII in talks on fill finishing Oxford University R21 malaria vaccine in Ghana: Expert Ruchika Sharma21 April 2023 1:15 PM ISTBengaluru: Vaccine manufacturer Serum Institute of India is holding talks on fill-finishing Oxford University's R21 malaria vaccine in Ghana, which...
University of Oxford Malaria vaccine gets regulatory clearance for use in Ghana Ruchika Sharma14 April 2023 12:07 PM ISTThe vaccine has been approved for use in children aged 5 to 36 months, the age group at highest risk of death from malaria.
Rise in COVID cases: Serum Institute restarts manufacturing of Covishield Ruchika Sharma13 April 2023 2:15 PM ISTNew Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine Covishield amid...
SII Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per dose Roshni Dhar12 April 2023 11:21 AM ISTIn view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion...
Health Bulletin 11/April/2023 Roshni Dhar11 April 2023 4:34 PM ISTHere are the top health stories for the day:Weekly cases up 79% as Covid hits more statesIndia has observed the highest weekly count of COVID...
Serum Institute Covovax likely to be available at Rs 225 per dose on CoWIN portal Ruchika Sharma10 April 2023 2:00 PM ISTCovovax was granted emergency-use listing by the World Health Organization on December 17, 2021.
COVID vaccine: SII seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults Ruchika Sharma4 April 2023 11:00 AM ISTCovovax is manufactured through technology transfer from US-based vaccine maker Novavax.
